Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2025-12-26 @ 3:58 AM
NCT ID:
NCT03255018
Group ID:
EG001
Title:
Cohort 2 Extra-nodal Diffuse Large B-cell Lymphoma (DLBCL)
Description:
Cohort 2: Extra-nodal diffuse large B-cell lymphoma involving one or more of the specified extra-nodal sites (i.e., extra-nodal DLBCL)
Participants will be treated with pembrolizumab 200 mg (flat dose) intravenous (IV) every 3 weeks provided they have clinical benefit and no unacceptable toxicity; participants who achieve a complete response (CR) will have the option to stop after 1 year of therapy.
Deaths Number Affected:
5
Deaths Number At Risk:
None
Serious Number Affected:
5
Serious Number At Risk:
9
Other Number Affected:
9
Other Number At Risk:
9
Study:
NCT03255018
Results Section:
NCT03255018
Adverse Events Module:
NCT03255018